Home > Signaling Pathways>Cell Cycle>PLK>NMS-P937 (NMS1286937; Onvansertib)
NMS-P937 (NMS1286937; Onvansertib)

This product is for research use only, not for human use. We do not sell to patients.

NMS-P937 (NMS1286937; Onvansertib)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
250mg$779Check With Us
500mg$1250Check With Us
1g$1875Check With Us

Cat #: V1580 CAS #: 1034616-18-6 Purity ≥ 98%

Description: NMS-P937 (also know as NMS-P937; NMS1286937; NMS-P-937; NMS-P 937; Onvansertib) is an orally bioavailable, potent, selective, small-molecule Polo-like Kinase 1 (PLK1) inhibitor with potential antitumor activity.

References: Beria I, et al. NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor. Bioorg Med Chem Lett. 2011 May 15; 21(10):2969-74.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)532.52
Molecular FormulaC24H27F3N8O3
CAS No.1034616-18-6
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 42 mg/mL (78.9 mM)r
Water:<1 mg/mLr
Ethanol: 10 mg/mL (18.8 mM)
SynonymsNMS-P937; NMS1286937; NMS-P-937; NMS-P 937; NMS 1286937; NMS-1286937
ProtocolIn VitroNMS-1286937 is a potent, selective, orally available PLK1 inhibitor, IC50 The value is 2 nM. NMS-1286937 also showed inhibitory activity against FLT3, MELK and CK2, IC50 The values are 510, 744, and 826 nM, respectively
In VivoNMS-1286937 (45 mg/kg, iv) demonstrated good tumor growth inhibition and acceptable and reversible weight loss in human HCT116 colon adenocarcinoma cell xenografted CD1 nu/nu mouse tumor models. NMS-1286937 (60 mg/kg, oral) also inhibits tumor growth on HCT116 tumor xenograft models
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM1.8779 mL9.3893 mL18.7786 mL37.5573 mL
5mM0.3756 mL1.8779 mL3.7557 mL7.5115 mL
10mM0.1878 mL0.9389 mL1.8779 mL3.7557 mL
20mM0.0939 mL0.4695 mL0.9389 mL1.8779 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.